Ballentine Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Buy
2,008
+9
+0.5% +$1.5K ﹤0.01% 779
2026
Q1
$420K Sell
1,999
-2
-0.1% -$503 0.01% 594
2025
Q4
$569K Sell
2,001
-24
-1% -$7.5K 0.01% 460
2025
Q3
$625K Buy
2,025
+3
+0.1% +$940 0.01% 431
2025
Q2
$635K Buy
2,022
+246
+14% +$71K 0.01% 414
2025
Q1
$467K Buy
1,776
+204
+13% +$55.2K 0.01% 466
2024
Q4
$411K Buy
1,572
+13
+0.8% +$3.27K 0.01% 486
2024
Q3
$363K Buy
1,559
+27
+2% +$5.54K 0.01% 523
2024
Q2
$309K Buy
1,532
+45
+3% +$8.11K 0.01% 550
2024
Q1
$255K Sell
1,487
-200
-12% -$37.3K ﹤0.01% 596
2023
Q4
$366K Buy
+1,687
New +$289K 0.01% 446
2023
Q2
Sell
-860
Closed -$274K 630
2023
Q1
$274K Buy
+860
New +$255K 0.01% 440

Other funds holding PODD

Ballentine Partners's PODD Position: Q2 2026 in Review

Ballentine Partners increased its Insulet (PODD) stake by 0.45% in Q2 2026, buying an estimated $1.5K and bringing the position to 2,008 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #779.

Ballentine Partners first reported a position in PODD in Q1 2023 and has held it in 12 quarters since. The position peaked at $635K in Q2 2025. 80 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Ballentine Partners held 2,008 shares of Insulet worth $306K as of Q2 2026.
  • Ballentine Partners bought 9 Insulet shares in Q2 2026, an estimated $1.5K.
  • Insulet made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #779 holding.
  • Ballentine Partners first reported a position in Insulet in Q1 2023 and has held it in 12 quarters since.
  • Ballentine Partners's Insulet position peaked at $635K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.